Lista de

CD8+ T lymphocyte
25
"Untangling Galectin-Driven Regulatory Circuits in Autoimmune Inflammation" (2018) Toscano, M.A.;Martínez Allo, V.C.;Cutine, A.M. (...)Mariño, K.V. Trends in Molecular Medicine. 24(4):348-363
"In vivo hemin conditioning targets the vascular and immunologic compartments and restrains prostate tumor development" (2017) Jaworski, F.M.;Gentilini, L.D.;Gueron, G. (...)Vazquez, E.S. Clinical Cancer Research. 23(17):5135-5148
"The Role of Heterotypic DENV-specific CD8+ T Lymphocytes in an Immunocompetent Mouse Model of Secondary Dengue Virus Infection" (2017) Talarico, L.B.;Batalle, J.P.;Byrne, A.B. (...)Polack, F.P. EBioMedicine. 20:202-216
"The Role of Heterotypic DENV-specific CD8+ T Lymphocytes in an Immunocompetent Mouse Model of Secondary Dengue Virus Infection" (2017) Talarico, L.B.;Batalle, J.P.;Byrne, A.B. (...)Polack, F.P. EBioMedicine. 20:202-216
"NK cells restrain spontaneous antitumor CD8+ T cell priming through pd-1/pd-l1 interactions with dendritic cells" (2016) Raffo Iraolagoitia, X.L.;Spallanzani, R.G.;Torres, N.I. (...)Fuertes, M.B. Journal of Immunology. 197(3):953-961
"NK cells restrain spontaneous antitumor CD8+ T cell priming through pd-1/pd-l1 interactions with dendritic cells" (2016) Raffo Iraolagoitia, X.L.;Spallanzani, R.G.;Torres, N.I. (...)Fuertes, M.B. Journal of Immunology. 197(3):953-961
"The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies" (2016) Sterle, H.A.;Barreiro Arcos, M.L.;Valli, E. (...)Cremaschi, G.A. Journal of Molecular Medicine. 94(4):417-429
"Thyroid hormones and their membrane receptors as therapeutic targets for T cell lymphomas" (2016) Cremaschi, G.A.;Cayrol, F.;Sterle, H.A. (...)Barreiro Arcos, M.L. Pharmacological Research. 109:55-63
"Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways" (2016) Rabinovich, G.A.; Conejo-García, J.R. Journal of Molecular Biology. 428(16):3266-3281
"Trypanosoma cruzi infection imparts a regulatory program in dendritic cells and T cells via galectin-1-dependent mechanisms" (2015) Poncini, C.V.;Ilarregui, J.M.;Batalla, E.I. (...)Rabinovich, G.A. Journal of Immunology. 195(7):3311-3324
"Dendritic cell-based vaccination in cancer: Therapeutic implications emerging from murine models" (2015) Mac Keon, S.; Ruiz, M.S.; Gazzaniga, S.; Wainstok, R. Frontiers in Immunology. 6(MAY)
"Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β" (2015) Alamino, V.A.;Mascanfroni, I.D.;Montesinos, M.M. (...)Pellizas, C.G. Cancer Research. 75(7):1265-1274
"Integration of lectin-glycan recognition systems and immune cell networks in CNS inflammation" (2014) Mendez-Huergo, S.P.;Maller, S.M.;Farez, M.F. (...)Rabinovich, G.A. Cytokine and Growth Factor Reviews. 25(3):247-255
"Glycobiology of cell death: When glycans and lectins govern cell fate" (2013) Lichtenstein, R.G.; Rabinovich, G.A. Cell Death and Differentiation. 20(8):976-986
"CD137 differentially regulates innate and adaptive immunity against Mycobacterium tuberculosis" (2012) Fernández Do Porto, D.A.;Jurado, J.O.;Pasquinelli, V. (...)García, V.E. Immunology and Cell Biology. 90(4):449-456
"Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments" (2012) Soldati, R.;Berger, E.;Zenclussen, A.C. (...)Fest, S. International Journal of Cancer. 131(5):1131-1141
"Oral administration of fluoxetine alters the proliferation/apoptosis balance of lymphoma cells and up-regulates T cell immunity in tumor-bearing mice" (2011) Frick, L.R.;Rapanelli, M.;Arcos, M.L.B. (...)Genaro, A.M. European Journal of Pharmacology. 659(2-3):265-272
"Serine leucocyte proteinase inhibitor-treated monocyte inhibits human CD4+ lymphocyte proliferation" (2011) Guerrieri, D.;Tateosian, N.L.;Maffía, P.C. (...)Chuluyan, H.E. Immunology. 133(4):434-441
"Chronic restraint stress impairs T-cell immunity and promotes tumor progression in mice" (2009) Frick, L.R.;Barreiro Arcos, M.L.;Rapanelli, M. (...)Cremaschi, G.A. Stress. 12(2):134-143
"Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis" (2008) Jurado, J.O.;Alvarez, I.B.;Pasquinelli, V. (...)García, V.E. Journal of Immunology. 181(1):116-125